When formulating this whistleblower reward and policy, Quantum BioPharma received legal opinions and comprehensive advice from multiple law firms/legal counsel, as well as the approval of its audit ...
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case ...
(RTTNews) - Quantum BioPharma Ltd. (QNTM) is having a banner year in 2025, with its share price skyrocketing 730% year-to-date. This biopharmaceutical company is focused on addressing critical unmet ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...
A New Model for the Modern Issuer BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology ...
Sets Record Date For Litigation-Linked CVR Distribution. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that Oct. 27, 2025 has been established as the record date for the distribution of conti ...
Getting in early on such a game-changing technology just might be the perfect example of how to make money by being in the ...
New Delhi can realize its quantum ambitions by concentrating on applications that intersect with its strengths and long term priorities.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback